Zunyi Wang
Overview
Explore the profile of Zunyi Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Liu Y, Yang C, Ma J, Li Y, Luo R, et al.
Breast Cancer Res
. 2025 Feb;
27(1):21.
PMID: 39948624
Background: Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer is the most common subtype of breast cancer, yet its response to traditional chemotherapy remains limited, posing a challenge...
2.
Wang P, Zhang Q, Zhang H, Shao J, Zhang H, Wang Z
PLoS One
. 2023 Dec;
18(12):e0293469.
PMID: 38127899
ICOS (Inducible T Cell Costimulator), one of the co-stimulatory B7 superfamily members, was characterized as a co-stimulatory receptor for T-cell enhancement. However, the role of ICOS in breast cancer remains...
3.
Zhang X, Li H, Wu F, Sun D, Zhang H, Jin L, et al.
Pak J Pharm Sci
. 2023 Aug;
36(2(Special)):619-623.
PMID: 37548199
To investigate the impact of Xihuang Capsule combined with albumin-bound paclitaxel on the treatment of stage III breast cancer and T cell subsets, survival rate and adverse reactions. Totally 200...
4.
Wang Z, Spitz R, Vezina C, Hou J, Bjorling D
Dis Model Mech
. 2023 Jun;
16(6).
PMID: 37283037
Lower urinary tract symptoms (LUTS) refer to various urological diseases, and incomplete bladder emptying is common among affected patients. The etiology of LUTS is largely unknown, and investigations of LUTS...
5.
Paul P, Das R, Drow T, Nylen E, Henrique de Souza A, Wang Z, et al.
Am J Transplant
. 2023 Mar;
23(5):693.
PMID: 36907701
No abstract available.
6.
Zhang H, Wang Z, Liu W, Wang P, Zhang X
Evid Based Complement Alternat Med
. 2023 Jan;
2023:5431563.
PMID: 36704213
Objectives: The aim of the study is to evaluate the efficacy and prognosis of neoadjuvant chemotherapy (NAC) combined with breast-conserving surgery (BCS) in treating triple-negative breast cancer (TNBC) and analyze...
7.
Zhang H, Zhang X, Jin L, Wang Z
Am J Transl Res
. 2022 Aug;
14(7):4648-4656.
PMID: 35958459
Objective: The purpose of this study was to evaluate the effect of neoadjuvant chemotherapy (NAC) on the responses and survival rates of patients with different molecular subtypes of breast cancer....
8.
Paul P, Das R, Drow T, Nylen E, Henrique de Souza A, Wang Z, et al.
Am J Transplant
. 2022 Jul;
22(11):2571-2585.
PMID: 35897156
Allogeneic islet transplantation is a promising experimental therapy for poorly controlled diabetes. Despite pharmacological immunosuppression, long-term islet engraftment remains elusive. Here, we designed a synthetic fusion transgene coupling PD-L1 and...
9.
Zhang Q, Gao C, Shao J, Zhang S, Wang P, Wang Z
Front Pharmacol
. 2022 Jul;
13:869877.
PMID: 35814211
Cancer immunotherapy is emerging as a novel promising therapy option for cancer patients. Despite the critical role of CD80 in the regulation of immune responses, the expression and biological functions...
10.
Jin L, Zhao Y, Wang P, Zhu R, Bai J, Li J, et al.
J Oncol
. 2022 Jul;
2022:2003324.
PMID: 35783153
Objective: To explore the influence of the whole-course case management model on the compliance and satisfaction of breast cancer patients with the whole-course standardized treatment. Methods: Eighty breast cancer patients...